within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03F_Propulsives.A03FA10_Acotiamide;

model Acotiamide
  extends Pharmacolibrary.Drugs.ATC.A.A03FA10;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A03FA10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Acotiamide is a gastroprokinetic agent used primarily for the treatment of functional dyspepsia. It works as an acetylcholinesterase inhibitor, enhancing gastric motility and improving gastric symptoms. Acotiamide is approved for use in Japan for functional dyspepsia but is not widely approved in other countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult Japanese volunteers (both sexes) after single oral administration.</p><h4>References</h4><ol><li><p>Li, J, et al., &amp; Zhao, Z (2016). Development and Validation of a Sensitive and Specific LC-MS-MS Method for the Determination of Acotiamide in Rat Plasma. <i>Journal of chromatographic science</i> 54(6) 1004–1009. DOI:<a href=\"https://doi.org/10.1093/chromsci/bmw035\">10.1093/chromsci/bmw035</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26980723/\">https://pubmed.ncbi.nlm.nih.gov/26980723</a></p></li><li><p>Zhu, P, et al., &amp; Zhuang, J (2011). A rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of olopatadine concentration in human plasma. <i>Journal of analytical toxicology</i> 35(2) 113–118. DOI:<a href=\"https://doi.org/10.1093/anatox/35.2.113\">10.1093/anatox/35.2.113</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21396231/\">https://pubmed.ncbi.nlm.nih.gov/21396231</a></p></li><li><p>Yu, HC, et al., &amp; Lin, YM (2016). Simultaneous determination of tedizolid and linezolid in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1011 94–98. DOI:<a href=\"https://doi.org/10.1016/j.jchromb.2015.12.056\">10.1016/j.jchromb.2015.12.056</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26773886/\">https://pubmed.ncbi.nlm.nih.gov/26773886</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Acotiamide;
